Sildenafil Tablet, Film Coated
Product Images NDC 63187-619

10 FDA label images from Proficient Rx Lp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 63187-619). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

63187-619-90 (20mg90s)

63187-619-90 (20mg90s)
Sildenafil 20 mg film coated tablets packaging label by Proficient Rx LP. The label indicates a bottle of 20 tablets, each containing 20 mg of sildenafil citrate. The tablets are described as white to off-white, round, biconvex, and film coated with debossed markings. The label includes manufacturer details (Hetero Labs Limited) and storage instructions.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A Kaplan-Meier curve graph showing estimated cumulative mortality rates over time for three dosage groups: high dose, medium dose, and low dose. The y-axis represents the estimated cumulative mortality rate in percentage, and the x-axis is the time in years. The graph includes a table indicating the number of subjects at risk at different time points for each dose group.*
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
A chart showing fold change and 90% confidence intervals for the area under the curve (AUC) and maximum concentration (Cmax) of Sildenafil when coadministered with various interacting drugs. The chart includes Atorvastatin, Azithromycin, Bosentan, Cimetidine, Erythromycin, Maalox, Oral Contraceptives, Ritonavir, and Saquinavir, with recommendations about dose adjustments and coadministration. The vertical solid line at x=1 indicates no change relative to Sildenafil alone.*
FDA Label Image

Figure3 (Figure3)

Figure3 (Figure3)
A forest plot chart showing fold change and 90% confidence intervals for various interacting drugs with Sildenafil. The horizontal axis represents change relative to interacting drug alone, with a vertical solid line at 1. Recommendations for dose adjustment are listed beside each drug interaction, mostly indicating no dose adjustment, except for ritonavir where coadministration is not recommended.*
FDA Label Image

Figure4 (Figure4)

Figure4 (Figure4)
A line graph showing changes from baseline over a 12-week study period with measurements taken at weeks 4, 8, and 12. The chart compares three groups: Lodenafil 40 mg TID, Placebo, and Sildenafil 20 mg TID, as indicated in the legend. The vertical axis represents change from baseline in meters, while the horizontal axis shows the week of study.*
FDA Label Image

Figure5 (Figure5)

Figure5 (Figure5)
A forest plot comparing placebo and Sildenafil 20 mg three times daily effect on 6-minute walk distance across various subgroups including baseline walk distance, etiology, pulmonary hypertension criteria, gender, age, mean pulmonary arterial pressure, and pulmonary vascular resistance index.*
FDA Label Image

Figure6 (Figure6)

Figure6 (Figure6)
A line graph comparing the percentage of patients without a clinically worsening event over days since randomization between placebo and Sildenafil groups. The y-axis represents the percentage without event, and the x-axis shows the days from randomization, with two distinct lines indicating the outcomes for placebo and Sildenafil.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of sildenafil shown as a 2D molecular diagram with labeled atoms and bonds, depicting its complex ring structures and functional groups.*
FDA Label Image

Address1 (Address1)

FDA Label Image

Address2 (Address2)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.